FDA updates labeling for BUPRENORPHINE HYDROCHLORIDE FDA Approval Dec. 31, 2025, 13:45 UTC 8 0 comments Labeling changes approved for HOSPIRA. Active ingredient: BUPRENORPHINE HYDROCHLORIDE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for SUBLIMAZE PRESERVATIVE FREE FDA Approval Dec. 31, 2025, 13:45 UTC 4 0 comments Labeling changes approved for RISING. Active ingredient: FENTANYL CITRATE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for NALBUPHINE HYDROCHLORIDE FDA Approval Dec. 31, 2025, 13:45 UTC 6 0 comments Labeling changes approved for HOSPIRA. Active ingredient: NALBUPHINE HYDROCHLORIDE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for NUCYNTA FDA Approval Dec. 31, 2025, 13:45 UTC 4 0 comments Labeling changes approved for COLLEGIUM PHARM INC. Active ingredient: TAPENTADOL HYDROCHLORIDE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for DILAUDID FDA Approval Dec. 31, 2025, 13:45 UTC 4 0 comments Labeling changes approved for RHODES PHARMS. Active ingredient: HYDROMORPHONE HYDROCHLORIDE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for DEMEROL FDA Approval Dec. 31, 2025, 13:45 UTC 8 0 comments Labeling changes approved for QUAGEN. Active ingredient: MEPERIDINE HYDROCHLORIDE. Decision date: 12/22/2025 Comment Full text
FDA regulatory update for ELELYSO FDA Approval Dec. 31, 2025, 13:45 UTC 2 0 comments Administrative update #SUPPL-34 for PFIZER. Status: Approval. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for MEPERGAN FDA Approval Dec. 31, 2025, 13:45 UTC 5 0 comments Labeling changes approved for HIKMA. Active ingredient: MEPERIDINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for MEPERIDINE HYDROCHLORIDE FDA Approval Dec. 31, 2025, 13:45 UTC 0 0 comments Labeling changes approved for HIKMA. Active ingredient: MEPERIDINE HYDROCHLORIDE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE FDA Approval Dec. 31, 2025, 13:45 UTC 7 0 comments Labeling changes approved for INGENUS PHARMS NJ. Active ingredient: ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE. Decision date: 12/22/2025 Comment Full text